248 related articles for article (PubMed ID: 17712918)
1. Treatment of adult ADHD and comorbid disorders.
Young JL
CNS Spectr; 2006 Oct; 11(10 Suppl 11):10-2. PubMed ID: 17712918
[No Abstract] [Full Text] [Related]
2. Non-stimulant trials of adult ADHD.
Adler LA
CNS Spectr; 2007 Apr; 12(4 Suppl 6):11-3. PubMed ID: 17717871
[No Abstract] [Full Text] [Related]
3. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Rowles BM; Findling RL
Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
[TBL] [Abstract][Full Text] [Related]
4. [The practice and problem of therapeutic agents for AD/HD].
Tanaka H; Miyajima T
No To Hattatsu; 2010 May; 42(3):213-6. PubMed ID: 23858580
[No Abstract] [Full Text] [Related]
5. Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder.
Stiefel G; Besag FM
Drug Saf; 2010 Oct; 33(10):821-42. PubMed ID: 20812768
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of attention-deficit hyperactivity disorder.
Reeves G; Schweitzer J
Expert Opin Pharmacother; 2004 Jun; 5(6):1313-20. PubMed ID: 15163276
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
[TBL] [Abstract][Full Text] [Related]
8. Current pharmacotherapy of attention deficit hyperactivity disorder.
Reddy DS
Drugs Today (Barc); 2013 Oct; 49(10):647-65. PubMed ID: 24191257
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.
Hennessy S; Schelleman H; Daniel GW; Bilker WB; Kimmel SE; Guevara J; Cziraky MJ; Strom BL
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):934-41. PubMed ID: 20623519
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of ADHD in adults.
Wilens TE
CNS Spectr; 2008 May; 13(5 Suppl 8):11-3. PubMed ID: 18567133
[No Abstract] [Full Text] [Related]
11. Pharmacology of adult ADHD with stimulants.
Spencer TJ
CNS Spectr; 2007 Apr; 12(4 Suppl 6):8-11. PubMed ID: 17715564
[No Abstract] [Full Text] [Related]
12. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
Bloch MH; Panza KE; Landeros-Weisenberger A; Leckman JF
J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):884-893. PubMed ID: 19625978
[TBL] [Abstract][Full Text] [Related]
13. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.
Peterson K; McDonagh MS; Fu R
Psychopharmacology (Berl); 2008 Mar; 197(1):1-11. PubMed ID: 18026719
[TBL] [Abstract][Full Text] [Related]
14. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
15. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
[TBL] [Abstract][Full Text] [Related]
16. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
Párraga HC; Párraga MI; Harris DK
Int J Psychiatry Med; 2007; 37(4):415-24. PubMed ID: 18441629
[TBL] [Abstract][Full Text] [Related]
17. Improving decision making in the treatment of ADHD.
Vitiello B
Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
[No Abstract] [Full Text] [Related]
18. Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.
Slatkoff J; Greenfield B
Expert Opin Investig Drugs; 2006 Jun; 15(6):649-67. PubMed ID: 16732717
[TBL] [Abstract][Full Text] [Related]
19. Mental illness and addiction issue brief: psychotropic medication and children: year end report-2004.
Rosenberg M
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-7. PubMed ID: 15744950
[No Abstract] [Full Text] [Related]
20. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.
Hanwella R; Senanayake M; de Silva V
BMC Psychiatry; 2011 Nov; 11():176. PubMed ID: 22074258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
